Pharmaceutical industry
Photo credits: pixabay.com
Commented by Lars Winter on October 20th, 2026 | 05:44 CEST
Gold, Money and Healthcare: Lahontan Gold, Goldman Sachs and Johnson & Johnson – 3 Promising Stocks Under Review
Canadian gold exploration company Lahontan Gold is generating optimism. A preliminary economic assessment of its key mining project in Nevada recently assigned the Santa Fe Mine a calculated project value of USD 820 million. This is a multiple of its current market capitalisation, giving the stock considerable upside potential. Goldman Sachs has also surprised the market in recent days with a strong set of financial results. Pharmaceutical giant Johnson & Johnson, meanwhile, raised its outlook despite one minor setback. Three promising companies with positive news are under review.
Read